Literature DB >> 6786734

Crystal structure of a carcinogen:nucleoside adduct.

H L Carrell, J P Glusker, R C Moschel, W R Hudgins, A Dipple.   

Abstract

The product of reaction between the carcinogen, 7-bromomethyl-12-methylbenz[a]anthracene, and 2'-deoxyadenosine, i.e., N6-(12-methylbenz[a]anthracenyl-7-methyl)deoxyadenosine, has been prepared and characterized, and its structure has been determined by X-ray crystallographic techniques. The major structural features are: (a) the adenine and polycyclic aromatic hydrocarbon residues lie nearly perpendicular to one another; (b) the conformation about the glycosidic bond is syn, rather than anti, and an internal hydrogen bond between the deoxyribose 5'-hydroxyl group and N(3) of the adenine residue is present; and (c) the more planar anthracene portion of the hydrocarbon is stacked between adenine residues of other molecules throughout the crystal.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6786734

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

Review 1.  Nucleic acid adducts of chemical carcinogens and mutagens.

Authors:  K Hemminki
Journal:  Arch Toxicol       Date:  1983-04       Impact factor: 5.153

2.  AAF linked to the guanine amino group: a B-Z junction.

Authors:  B Hingerty; S Broyde
Journal:  Nucleic Acids Res       Date:  1983-05-25       Impact factor: 16.971

3.  Identification and characterization of 2'-deoxyadenosine adducts formed by isoprene monoepoxides in vitro.

Authors:  Petra Begemann; Gunnar Boysen; Nadia I Georgieva; Ramiah Sangaiah; Karl M Koshlap; Hasan Koc; Daping Zhang; Bernard T Golding; Avram Gold; James A Swenberg
Journal:  Chem Res Toxicol       Date:  2011-06-09       Impact factor: 3.739

4.  Crystal and molecular structure of a benzo[a]pyrene 7,8-diol 9,10-epoxide N2-deoxyguanosine adduct: absolute configuration and conformation.

Authors:  Isabella L Karle; Haruhiko Yagi; Jane M Sayer; Donald M Jerina
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-02       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.